Contract Research Organization, WCCT Global, Announces Attendance at the 2014 American Society of Cataract and Refractive Surgery Conference
COSTA MESA, Calif., April 24, 2014 /PRNewswire-iReach/ — WCCT Global, a full service contract research organization announces today they will be in attendance at the 2014 American Society of Cataract and Refractive Surgery ophthalmology conference in Boston, Massachusetts. The Full Service CRO will be exhibiting at booth #1304. In attendance from WCCT Global will be key personnel specializing in early and late phase ophthalmology clinical research to discuss our specialty clinical research capabilities. WCCT Global has expanded their ophthalmology research capabilities by joining forces with some key Southern California ophthalmology research sites, including Michael Sheety, MD. Dr. Sheety joined WCCT Global as Medical and Surgery Director of Ophthalmology and Aesthetics. He has brought a wealth of knowledge and experience to the team. The attendees from WCCT Global will be present to discuss how WCCT Global can be of assistance with Ophthalmology study design, logistics and execution. WCCT Global offers a unique alternative for pharmaceutical companies by not only having their ophthalmology research center located in Southern California, but also having their Clinical Pharmacology Units conveniently located in Southern California, which allows for flexibility if special ophthalmology treatments are needed for extended stay clinical trials. WCCT Global’s goal is to offer the Ophthalmic Pharmaceutical Industry innovative solutions for clinical research ranging from study design to study reporting and publication for all ophthalmology related research programs.
More Information about WCCT Global, Full Service CRO capabilities:
WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you are interested in how WCCT Global can service one of your upcoming clinical studies, CLICK HERE.
Media Contact: Matt Miller, WCCT Global, 714.668.1500 ext.2029, Matt.Miller@wcct.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WCCT Global